RECENT NEWS
The Hindu Business Line  Nov 20  Comment 
Scientists are developing a functional bioartificial kidney which could replace the need for dialysis or organ transplant in the millions of patients who suffer from kidney failure. A key requireme...
MedPage Today  Nov 18  Comment 
(MedPage Today) -- Risks for hospitalization, dialysis discontinuation also higher
NPR  Oct 4  Comment 
Nationwide, fewer than 10 percent of people who need kidney dialysis do it at home. But close to 40 percent of patients of a Montana doctor do it at home. Medicare is hoping that becomes a trend.
Benzinga  Sep 29  Comment 
Brean Capital assumes coverage of Akebia Therapeutics Inc (NASDAQ: AKBA) with a Buy rating, with a lowered target price of $18, citing potential success of its anemia drug. The company's lead product candidate, AKB-6548 or vadadustat is a small...
MedPage Today  Sep 23  Comment 
(MedPage Today) -- Conservative management option rarely offered
newratings.com  Sep 2  Comment 
Fresenius Medical Care AG & Co. KGaA acquires dialysis service provider Sandor Nephro Services in India DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Investment Fresenius Medical Care AG & Co. KGaA acquires dialysis service...
The Economic Times  Aug 31  Comment 
“We will put our point that drugs of cancer drugs used in dialysis and other important life saving drugs should also be exempt from the GST."
newratings.com  Aug 25  Comment 
DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) announced an agreement to provide patients with the latest advancements in peritoneal dialysis, hemodialysis and continuous renal replacement therapy. As per the four-year agreement, Satellite...
The Hindu Business Line  Aug 24  Comment 
Dialysis service provider NephroPlus on Wednesday announced that it has raised ₹100 crore in Series C funding led by SeaLink Capital Partners (SCP) and International Finance Corporation, a member of ...




RELATED WIKI ARTICLES
 

Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki